ArticleBMJ (Clinical research ed.)2018

Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study.

Peter Ueda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.